News

  • Dr Laura Moffitt

    CanToo funding boost for ovarian cancer research

    One of the most exciting developments in ovarian cancer treatment in decades will form the basis of a new two-year research project at Hudson Institute, thanks to the generosity of the CanToo Foundation.…  Read more

  • Associate Professor Simon Chu and Dr Nicole Campbell

    Hope for ovarian cancer – thanks to OCRF funding

    Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding distribution from the Ovarian Cancer Research Foundation (OCRF), offering hope to women everywhere.…  Read more

  • Pouya, Tima, Grace Tour De Cure Grants

    Hudson Lab Secures Three Grants to Battle Childhood Cancers

    In a significant advancement for pediatric cancer research, Dr Pouya Faridi—the head of the Translational Antigen Discovery Laboratory and Childhood Cancer Immunotherapy Program Lead—announced that his lab has been awarded three grants from Tour de Cure Australia.…  Read more

  • Dr Paul Daniel, Dr Shazia Adjumain and Professor Ron Firestein

    One-two punch targets childhood brain cancer

    The latest discovery packs a double punch – identifying a genetic target for childhood brain cancer, plus a way to determine which patients are mostly likely to benefit from it.…  Read more

  • Tamara Yawno International Women’s Day

    Extracellular vesicles: A promising frontier in treating preterm brain injury

    Despite advances in neonatal care, effective treatments for brain injury in premature babies remain a significant unmet need. Researchers at Hudson Institute of Medical Research, working with the School of Clinical Sciences at Monash Health, are tackling this challenge head-on with an innovative approach: engineered extracellular vesicles.…  Read more

  • Endometriosis 2025 – all your questions answered

    Endometriosis researchers, Professor Caroline Gargett and Dr Fiona Cousins answer your most frequently asked questions relating to this chronic inflammatory disease effecting one-in-seven menstruating people. …  Read more

  • An advanced-stage tumor after 8 weeks, showing specific areas where cancer-spreading leader cells (KRT14+ LCs) and immune-suppressing cells (Tregs) are concentrated, driving tumor growth and immune evasion

    Leader cells key to stopping ovarian cancer’s double impact

    A diagnosis of ovarian cancer carries a dual threat – the disease itself and the danger of the cancer spreading – but the latest research from Hudson Institute has uncovered a crucial factor, leader cells, that are crucial to both.…  Read more

  • NHMRC Investigator Grants 2025 Feature

    NHMRC Investigator grant success 2025

    Research projects that will improve the lives of people with autoinflammatory diseases, hypertension, cancer and perinatal brain injury have been recognised in the latest National Health and Medical Research Council (NHMRC) Investigator Grants, announced by Federal Minister for Health and Ageing, The Hon Mark Butler MP.…  Read more

  • Dr Robert Galinsky and Ms Nhi Tran from the Perinatal Transition Research Group at Hudson Institute

    Creatine & pregnancy – good for baby’s brain

    There is growing evidence that creatine may be beneficial as a pregnancy supplement, and new research from Hudson Institute suggests it could have benefits in protecting the brain when a baby is starved of oxygen.…  Read more

  • Baby fetal brain monitoring sq

    AI-based fetal monitoring to prevent perinatal brain injury

    A new AI-driven approach to fetal brain health monitoring will enable early detection of fetal distress, allowing for timely interventions to prevent brain damage and reducing unnecessary medical interventions, thanks to Monash Institute of Medical Engineering (MIME) project grant support.…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected